Header Logo

Connection

Sue Leurgans to Alzheimer Disease

Back to Details
This is a "connection" page, showing publications Sue Leurgans has written about Alzheimer Disease.
Sue Leurgans
Connection Strength
4.954
Alzheimer Disease
  1. Is there a link between cancer and Alzheimer disease? Neurology. 2010 Jan 12; 74(2):100-1.
    View in: PubMed
    Score: 0.159
  2. High-throughput digital quantification of Alzheimer disease pathology and associated infrastructure in large autopsy studies. J Neuropathol Exp Neurol. 2023 Nov 20; 82(12):976-986.
    View in: PubMed
    Score: 0.105
  3. Neuropathologic correlates of cerebral microbleeds in community-based older adults. Neurobiol Aging. 2023 09; 129:89-98.
    View in: PubMed
    Score: 0.101
  4. Trends in Postmortem Neurodegenerative and Cerebrovascular Neuropathologies Over 25 Years. JAMA Neurol. 2023 04 01; 80(4):370-376.
    View in: PubMed
    Score: 0.100
  5. Association of Mediterranean-DASH Intervention for Neurodegenerative Delay and Mediterranean Diets With Alzheimer Disease Pathology. Neurology. 2023 05 30; 100(22):e2259-e2268.
    View in: PubMed
    Score: 0.100
  6. Acculturation in Context and Brain Health in Older Latino Adults: A Diffusion Tensor Imaging Study. J Alzheimers Dis. 2023; 95(4):1585-1595.
    View in: PubMed
    Score: 0.098
  7. Alzheimer's Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia. J Alzheimers Dis. 2023; 96(2):563-578.
    View in: PubMed
    Score: 0.098
  8. Brain copper may protect from cognitive decline and Alzheimer's disease pathology: a community-based study. Mol Psychiatry. 2022 10; 27(10):4307-4313.
    View in: PubMed
    Score: 0.097
  9. Cognitive decline and hippocampal functional connectivity within older Black adults. Hum Brain Mapp. 2022 11; 43(16):5044-5052.
    View in: PubMed
    Score: 0.096
  10. Longitudinal change in serial position scores in older adults with entorhinal and hippocampal neuropathologies. J Int Neuropsychol Soc. 2023 Jul; 29(6):561-571.
    View in: PubMed
    Score: 0.096
  11. Limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) is associated with lower R2 relaxation rate: an ex-vivo MRI and pathology investigation. Neurobiol Aging. 2022 09; 117:128-138.
    View in: PubMed
    Score: 0.094
  12. Modifiable psychosocial risk factors and delayed onset of dementia in older populations: analysis of two prospective US cohorts. BMJ Open. 2022 04 04; 12(4):e059317.
    View in: PubMed
    Score: 0.093
  13. Association of Traumatic Brain Injury With and Without Loss of Consciousness With Neuropathologic Outcomes in Community-Dwelling Older Persons. JAMA Netw Open. 2022 04 01; 5(4):e229311.
    View in: PubMed
    Score: 0.093
  14. Quantifying longitudinal cognitive resilience to Alzheimer's disease and other neuropathologies. Alzheimers Dement. 2022 11; 18(11):2252-2261.
    View in: PubMed
    Score: 0.092
  15. Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study. J Alzheimers Dis. 2022; 88(2):653-661.
    View in: PubMed
    Score: 0.092
  16. Relationship of Purpose in Life to Dementia in Older Black and White Brazilians. J Int Neuropsychol Soc. 2022 11; 28(10):997-1002.
    View in: PubMed
    Score: 0.090
  17. ARTS: A novel In-vivo classifier of arteriolosclerosis for the older adult brain. Neuroimage Clin. 2021; 31:102768.
    View in: PubMed
    Score: 0.089
  18. Acculturation in Context: The Relationship Between Acculturation and Socioenvironmental Factors With Level of and Change in Cognition in Older Latinos. J Gerontol B Psychol Sci Soc Sci. 2021 03 14; 76(4):e129-e139.
    View in: PubMed
    Score: 0.087
  19. Systemic brain derived neurotrophic factor but not intestinal barrier integrity is associated with cognitive decline and incident Alzheimer's disease. PLoS One. 2021; 16(3):e0240342.
    View in: PubMed
    Score: 0.087
  20. MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults. J Alzheimers Dis. 2021; 83(2):683-692.
    View in: PubMed
    Score: 0.086
  21. Representation of Older Latinxs in Cohort Studies at the Rush Alzheimer's Disease Center. Neuroepidemiology. 2020; 54(5):404-418.
    View in: PubMed
    Score: 0.084
  22. Dietary flavonols and risk of Alzheimer dementia. Neurology. 2020 04 21; 94(16):e1749-e1756.
    View in: PubMed
    Score: 0.080
  23. Alzheimer's disease frequency peaks in the tenth decade and is lower afterwards. Acta Neuropathol Commun. 2019 07 03; 7(1):104.
    View in: PubMed
    Score: 0.077
  24. Physical activity, common brain pathologies, and cognition in community-dwelling older adults. Neurology. 2019 02 19; 92(8):e811-e822.
    View in: PubMed
    Score: 0.075
  25. Statistical Methodology for Multiclass Classifications: Applications to Dementia. J Alzheimers Dis. 2019; 68(1):173-186.
    View in: PubMed
    Score: 0.074
  26. Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies. Ann Neurol. 2019 01; 85(1):114-124.
    View in: PubMed
    Score: 0.074
  27. Circulating Dkk1 and TRAIL Are Associated With Cognitive Decline in Community-Dwelling, Older Adults With Cognitive Concerns. J Gerontol A Biol Sci Med Sci. 2018 11 10; 73(12):1688-1694.
    View in: PubMed
    Score: 0.074
  28. TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease. Acta Neuropathol Commun. 2018 05 01; 6(1):33.
    View in: PubMed
    Score: 0.071
  29. Decline in Literacy and Incident AD Dementia Among Community-Dwelling Older Persons. J Aging Health. 2018 10; 30(9):1389-1405.
    View in: PubMed
    Score: 0.067
  30. Entorhinal Cortex: Antemortem Cortical Thickness and Postmortem Neurofibrillary Tangles and Amyloid Pathology. AJNR Am J Neuroradiol. 2017 May; 38(5):961-965.
    View in: PubMed
    Score: 0.066
  31. Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology. Alzheimer Dis Assoc Disord. 2017 Jan-Mar; 31(1):41-47.
    View in: PubMed
    Score: 0.065
  32. Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease. Acta Neuropathol. 2017 03; 133(3):395-407.
    View in: PubMed
    Score: 0.064
  33. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol. 2016 08; 15(9):934-943.
    View in: PubMed
    Score: 0.062
  34. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology. 2015 Dec 01; 85(22):1930-6.
    View in: PubMed
    Score: 0.060
  35. Mixed pathology is more likely in black than white decedents with Alzheimer dementia. Neurology. 2015 Aug 11; 85(6):528-34.
    View in: PubMed
    Score: 0.059
  36. Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease. Ann Neurol. 2015 Jun; 77(6):942-52.
    View in: PubMed
    Score: 0.058
  37. Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. JAMA Neurol. 2015 Jan; 72(1):15-24.
    View in: PubMed
    Score: 0.056
  38. Author response. Neurology. 2014 Sep 30; 83(14):1302.
    View in: PubMed
    Score: 0.055
  39. Cortical pyroglutamate amyloid-? levels and cognitive decline in Alzheimer's disease. Neurobiol Aging. 2015 Jan; 36(1):12-9.
    View in: PubMed
    Score: 0.054
  40. Associations of cerebrovascular and Alzheimer's disease pathology with brain atrophy. Curr Alzheimer Res. 2014 May; 11(4):309-16.
    View in: PubMed
    Score: 0.054
  41. Contribution of Alzheimer disease to mortality in the United States. Neurology. 2014 Mar 25; 82(12):1045-50.
    View in: PubMed
    Score: 0.053
  42. Ex vivo T2 relaxation: associations with age-related neuropathology and cognition. Neurobiol Aging. 2014 Jul; 35(7):1549-61.
    View in: PubMed
    Score: 0.053
  43. Reply to Itzhaki and Klapper. J Infect Dis. 2014 Mar; 209(6):974.
    View in: PubMed
    Score: 0.052
  44. Resilient brain aging: characterization of discordance between Alzheimer's disease pathology and cognition. Curr Alzheimer Res. 2013 Oct; 10(8):844-51.
    View in: PubMed
    Score: 0.052
  45. Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis. 2013 Aug 15; 208(4):564-72.
    View in: PubMed
    Score: 0.050
  46. APOE e4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death. Psychol Aging. 2013 Dec; 28(4):1015-23.
    View in: PubMed
    Score: 0.050
  47. Hippocampal proNGF signaling pathways and ?-amyloid levels in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol. 2012 Nov; 71(11):1018-29.
    View in: PubMed
    Score: 0.049
  48. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain. 2012 Oct; 135(Pt 10):3005-14.
    View in: PubMed
    Score: 0.048
  49. A random change point model for cognitive decline in Alzheimer's disease and mild cognitive impairment. Neuroepidemiology. 2012; 39(2):73-83.
    View in: PubMed
    Score: 0.048
  50. Cognitive reserve, presynaptic proteins and dementia in the elderly. Transl Psychiatry. 2012 May 15; 2:e114.
    View in: PubMed
    Score: 0.047
  51. Dementia from Alzheimer disease and mixed pathologies in the oldest old. JAMA. 2012 May 02; 307(17):1798-800.
    View in: PubMed
    Score: 0.047
  52. Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease. Neurobiol Aging. 2013 Jan; 34(1):157-68.
    View in: PubMed
    Score: 0.047
  53. The CETP I405V polymorphism is associated with an increased risk of Alzheimer's disease. Aging Cell. 2012 Apr; 11(2):228-33.
    View in: PubMed
    Score: 0.046
  54. A genome-wide scan for common variants affecting the rate of age-related cognitive decline. Neurobiol Aging. 2012 May; 33(5):1017.e1-15.
    View in: PubMed
    Score: 0.045
  55. Hemoglobin level in older persons and incident Alzheimer disease: prospective cohort analysis. Neurology. 2011 Jul 19; 77(3):219-26.
    View in: PubMed
    Score: 0.044
  56. CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol. 2011 Mar; 69(3):560-9.
    View in: PubMed
    Score: 0.043
  57. Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. Arch Neurol. 2011 Mar; 68(3):351-6.
    View in: PubMed
    Score: 0.043
  58. Heritability of different forms of memory in the Late Onset Alzheimer's Disease Family Study. J Alzheimers Dis. 2011; 23(2):249-55.
    View in: PubMed
    Score: 0.043
  59. Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States. Alzheimers Dement. 2011 Jan; 7(1):74-9.
    View in: PubMed
    Score: 0.043
  60. Telephone assessment of cognitive function in the late-onset Alzheimer's disease family study. Arch Neurol. 2010 Jul; 67(7):855-61.
    View in: PubMed
    Score: 0.041
  61. Inability of plasma and urine F2A-isoprostane levels to differentiate mild cognitive impairment from Alzheimer's disease. Neurodegener Dis. 2010; 7(1-3):139-42.
    View in: PubMed
    Score: 0.040
  62. MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD. Neurobiol Aging. 2011 Oct; 32(10):1756-64.
    View in: PubMed
    Score: 0.040
  63. Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons. Arch Neurol. 2009 Nov; 66(11):1339-44.
    View in: PubMed
    Score: 0.039
  64. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009 Aug; 66(2):200-8.
    View in: PubMed
    Score: 0.039
  65. Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles. Neurology. 2009 Apr 28; 72(17):1495-503.
    View in: PubMed
    Score: 0.038
  66. Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function. Neurobiol Aging. 2010 Jul; 31(7):1089-98.
    View in: PubMed
    Score: 0.037
  67. Physical frailty in older persons is associated with Alzheimer disease pathology. Neurology. 2008 Aug 12; 71(7):499-504.
    View in: PubMed
    Score: 0.036
  68. Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis. Neurology. 2007 Mar 06; 68(10):757-63.
    View in: PubMed
    Score: 0.033
  69. Association of daytime napping and Parkinsonian signs in Alzheimer's disease. Sleep Med. 2006 Dec; 7(8):614-8.
    View in: PubMed
    Score: 0.032
  70. Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci U S A. 2006 Jun 27; 103(26):10041-5.
    View in: PubMed
    Score: 0.031
  71. White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging. 2006 May; 27(5):663-72.
    View in: PubMed
    Score: 0.029
  72. MRI predictors of risk of incident Alzheimer disease: a longitudinal study. Neurology. 2005 May 10; 64(9):1520-4.
    View in: PubMed
    Score: 0.029
  73. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging. 2004 Oct; 25(9):1197-203.
    View in: PubMed
    Score: 0.028
  74. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. Arch Neurol. 2003 Aug; 60(8):1143-8.
    View in: PubMed
    Score: 0.026
  75. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol. 2002 Feb 04; 443(2):136-53.
    View in: PubMed
    Score: 0.023
  76. A? (Amyloid Beta) and Tau Tangle Pathology Modifies the Association Between Small Vessel Disease and Cortical Microinfarcts. Stroke. 2021 03; 52(3):1012-1021.
    View in: PubMed
    Score: 0.022
  77. Association of serial position scores on memory tests and hippocampal-related neuropathologic outcomes. Neurology. 2020 12 15; 95(24):e3303-e3312.
    View in: PubMed
    Score: 0.021
  78. Total daily physical activity, brain pathologies, and parkinsonism in older adults. PLoS One. 2020; 15(4):e0232404.
    View in: PubMed
    Score: 0.020
  79. Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults. J Alzheimers Dis. 2020; 73(1):333-345.
    View in: PubMed
    Score: 0.020
  80. Associations of amygdala volume and shape with transactive response DNA-binding protein 43 (TDP-43) pathology in a community cohort of older adults. Neurobiol Aging. 2019 05; 77:104-111.
    View in: PubMed
    Score: 0.019
  81. Postmortem neurodegenerative markers and trajectories of decline in cognitive systems. Neurology. 2019 02 19; 92(8):e831-e840.
    View in: PubMed
    Score: 0.019
  82. Neurodegenerative disease and cognitive retest learning. Neurobiol Aging. 2018 06; 66:122-130.
    View in: PubMed
    Score: 0.018
  83. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol. 2018 01; 83(1):74-83.
    View in: PubMed
    Score: 0.017
  84. Postmortem MRI: a novel window into the neurobiology of late life cognitive decline. Neurobiol Aging. 2016 09; 45:169-177.
    View in: PubMed
    Score: 0.016
  85. APOE and cerebral amyloid angiopathy in community-dwelling older persons. Neurobiol Aging. 2015 Nov; 36(11):2946-2953.
    View in: PubMed
    Score: 0.015
  86. Neuropathologic correlates of regional brain volumes in a community cohort of older adults. Neurobiol Aging. 2015 Oct; 36(10):2798-805.
    View in: PubMed
    Score: 0.015
  87. Effect of common neuropathologies on progression of late life cognitive impairment. Neurobiol Aging. 2015 Jul; 36(7):2225-2231.
    View in: PubMed
    Score: 0.014
  88. Microinfarct pathology, dementia, and cognitive systems. Stroke. 2011 Mar; 42(3):722-7.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.